Clinical trials for Twin-reversed arterial perfusion sequence
10 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06550011Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)Avirmax Biopharma Inc
- RECRUITINGNCT06821919Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)Western Galilee Hospital-Nahariya
- ACTIVE NOT RECRUITINGNCT07194915Pleural Fluid Neutrophil Extracellular Traps Exacerbate Disease Severity and Risk of One-year Mortality in Pleural Infection (TORPIDS-3)University of Oxford
- RECRUITINGNCT06412822Neutrophil Extracellular Traps (NET's) in Prevalent Kidney StoneBrugmann University Hospital · PI: Agnieszka POZDZIK
- RECRUITINGN/ANCT05711173Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)University Hospital, Bordeaux · PI: Alexandre GUY
- ACTIVE NOT RECRUITINGNCT07185646Mechanistic Study of SPARC-Mediated Regulation of Neutrophil Extracellular Trap Formation in the Brain Metastatic Microenvironment of Breast CancerSecond Xiangya Hospital of Central South University
- RECRUITINGNCT05056857Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking TamoxifenM.D. Anderson Cancer Center · PI: Jyotika Sharma
- ACTIVE NOT RECRUITINGPhase 2NCT04784416Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)NYU Langone Health · PI: Dan Iosifescu, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03787680Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)University of Michigan Rogel Cancer Center · PI: Zachery Reichert, M.D.
- RECRUITINGPHASE1, PHASE2NCT03109288Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)National Institute of Allergy and Infectious Diseases (NIAID) · PI: Bibiana Bielekova, M.D.